Role of the ubiquitin proteasome system in Alzheimer's disease.
about
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's diseaseA novel brain-enriched E3 ubiquitin ligase RNF182 is up regulated in the brains of Alzheimer's patients and targets ATP6V0C for degradationA novel neuron-enriched protein SDIM1 is down regulated in Alzheimer's brains and attenuates cell death induced by DNAJB4 over-expression in neuro-progenitor cellsPaired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomesProtein phosphatases and Alzheimer's diseaseThe ubiquitin proteasomal system: a potential target for the management of Alzheimer's diseaseThe Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord InjuryiTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and diseaseNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Cell-cell adhesion defects in Mrj mutant trophoblast cells are associated with failure to pattern the chorion during early placental developmentThe ubiquitin system, disease, and drug discovery.Viable mouse gene ablations that robustly alter brain Aβ levels are rare.A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancerThe ubiquitin-proteasome pathway and synaptic plasticity.Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.Curcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a component of the ESCRT-II complex.Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of β-secretase.Identification of Differentially Expressed Genes through Integrated Study of Alzheimer's Disease Affected Brain RegionsCoordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP.Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.PathNet: a tool for pathway analysis using topological informationMolecular events linking cholesterol to Alzheimer's disease and inclusion body myositis in a rabbit model.Brain site-specific proteome changes in aging-related dementia.18α-Glycyrrhetinic Acid Proteasome Activator Decelerates Aging and Alzheimer's Disease Progression in Caenorhabditis elegans and Neuronal Cultures.Genetic ablation of calcium-independent phospholipase A2{gamma} leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction.The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's diseaseLysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease.Proteins that accumulate with age in human skeletal-muscle aggregates contribute to declines in muscle mass and function in Caenorhabditis elegansProtein Quality Control by Molecular Chaperones in Neurodegeneration.Proteomics moves from expression to turnover: update and future perspective.Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.Neuronal ubiquitin homeostasisThe proteasome function reporter GFPu accumulates in young brains of the APPswe/PS1dE9 Alzheimer's disease mouse model.Oxidative Stress and Protein Quality Control Systems in the Aged Canine Brain as a Model for Human Neurodegenerative Disorders.The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders.Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.UPS Activation in the Battle Against Aging and Aggregation-Related Diseases: An Extended Review.Proteolysis, synaptic plasticity and memory.
P2860
Q21091189-47904D4E-7276-4ADC-B9EF-79E6BA335181Q24317350-8C85EB16-9114-404A-BD64-4EF5D7D0B608Q24337904-ABA454C5-6757-4944-BFA5-2E08A0F0F177Q24608787-914818CF-0DDB-4CAE-BEFC-49E8F9364C30Q24632495-B94C8177-0F19-4786-B547-A3ED070A42C0Q26749321-C22EA06C-9CF1-46E7-881C-2AA152AB0D94Q26767879-BB68F2A8-4C45-457B-8D3D-3A6E03406FE0Q27300851-1D09C07F-467D-45D6-BC13-6DD166ED312DQ28070156-EECEAB2D-2DAB-4633-9F68-D7C037B71F20Q28513614-99D58D02-D4D4-489D-9CE5-127CFEFB4B72Q33384295-5FD73225-6306-4C46-82EA-F6C656032442Q33739902-4D7A40EE-02C4-4064-B83D-7CCF7FFDA2A3Q33860823-98A1E243-B889-43A2-9FD3-EF5C3771C906Q33994715-500369F5-FED2-4EF9-9BAB-44582CE5B0B4Q34372681-786F0617-43EE-4C0E-A34E-4D08EF4CC3FDQ34374859-B038B3C8-6E82-48DC-BF9D-21840BCA51FAQ34933261-F0C8D1EE-AEDB-4A6C-8751-987B45FA54CAQ35132073-052AD017-1E12-41D6-94EC-1F7884B5ABBEQ35935156-11B870F0-553F-493A-9860-DCCF06CF2113Q35981049-46BC1343-8DAC-4715-BD97-8E138409C708Q36072006-A0DB34D8-683B-4A66-A08A-23D87696535FQ36243522-932D4844-25B1-46CC-BD84-C17FD4C06474Q36585204-053B9587-414E-44FF-A57F-D65DDFE7D428Q36678662-51317430-ADCC-43F6-992D-58DC8DD2AA85Q37212178-AAF8757A-ED3C-400B-B261-770534AD0243Q37443865-8AFD10F0-54FB-4B62-A2C0-69AD1751E626Q37467636-5A5A8A52-B0EF-4EB9-845D-839C0C95ADCCQ37474466-53DEB911-8ACB-49C5-B709-8CD80B9FBCBEQ37568914-4F2A27E2-2B0A-49EA-87C7-06A7AA191529Q37610211-72259077-8089-4442-92B5-954686721327Q37739093-A9EA0EBF-7929-40F5-923E-22C738F88B18Q37890419-E825BF1E-6924-4E56-9145-4BBBB17BABABQ37955915-3B2D034D-9645-4B11-9AE2-CA84313C29B5Q38107854-5177D336-4AD4-4DD8-AD7B-89324662F193Q38280133-C2CDB852-C096-4576-BEDC-F837011A4650Q38528923-4783FEB4-3D05-41A3-9576-9F08B2C9459DQ38805509-0C3F7E7B-CCDA-4329-9AAB-F904B77AD23BQ38942540-77E81914-3BD9-4BFD-B0DA-D4B5932C09A9Q38950512-EB2BBE55-D596-45DE-8759-9583B1863206Q38950862-3BA98674-C016-4CD1-B4AD-49B05E310E93
P2860
Role of the ubiquitin proteasome system in Alzheimer's disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Role of the ubiquitin proteasome system in Alzheimer's disease.
@ast
Role of the ubiquitin proteasome system in Alzheimer's disease.
@en
Role of the ubiquitin proteasome system in Alzheimer's disease.
@nl
type
label
Role of the ubiquitin proteasome system in Alzheimer's disease.
@ast
Role of the ubiquitin proteasome system in Alzheimer's disease.
@en
Role of the ubiquitin proteasome system in Alzheimer's disease.
@nl
prefLabel
Role of the ubiquitin proteasome system in Alzheimer's disease.
@ast
Role of the ubiquitin proteasome system in Alzheimer's disease.
@en
Role of the ubiquitin proteasome system in Alzheimer's disease.
@nl
P2860
P921
P1433
P1476
Role of the ubiquitin proteasome system in Alzheimer's disease.
@en
P2093
Ashok N Hegde
Sudarshan C Upadhya
P2860
P2888
P356
10.1186/1471-2091-8-S1-S12
P478
P5008
P577
2007-11-22T00:00:00Z
P5875
P6179
1023743592